145 related articles for article (PubMed ID: 10083316)
1. Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells.
Geissler EK; Graeb C; Jauch KW; Scherer MN
Transplant Proc; 1999; 31(1-2):742-3. PubMed ID: 10083316
[No Abstract] [Full Text] [Related]
2. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
Graeb C; Scherer MN; Knechtle SJ; Geissler EK
Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.
Graeb C; Scherer MN; Kroemer A; Jauch KW; Geissler EK
Hum Immunol; 2002 Oct; 63(10):948-54. PubMed ID: 12368047
[TBL] [Abstract][Full Text] [Related]
4. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
Rosenberg AS; Mizuochi T; Singer A
J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
6. Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen.
Wang M; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1999 May; 31(3):1517-8. PubMed ID: 10330987
[No Abstract] [Full Text] [Related]
7. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system.
Sedgwick JD; Mössner R; Schwender S; ter Meulen V
J Exp Med; 1991 May; 173(5):1235-46. PubMed ID: 1827142
[TBL] [Abstract][Full Text] [Related]
9. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
Clement JD; Chan SY; Bishop DK
Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
[TBL] [Abstract][Full Text] [Related]
11. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens.
Singer A; Munitz TI; Golding H; Rosenberg AS; Mizuochi T
Immunol Rev; 1987 Aug; 98():143-70. PubMed ID: 2958403
[TBL] [Abstract][Full Text] [Related]
12. Modulation of alloimmunity to major histocompatibility complex class I by cotransfer of cytokine genes in vivo.
Zhai Y; Hong X; Wang J; Fechner JH; Goodman RE; Johnson MC; Knechtle SJ
Transpl Immunol; 1998 Sep; 6(3):169-75. PubMed ID: 9848223
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
Lake JP; Kapp JA; Pierce CW
J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
[TBL] [Abstract][Full Text] [Related]
14. Effect of portal vein injection of allo-MHC-transfected hepatocytes on immunity prior to organ transplantation.
Graeb C; Geissler EK
Transplant Proc; 1997; 29(1-2):1017-9. PubMed ID: 9123177
[No Abstract] [Full Text] [Related]
15. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
Williams FH; Thiele DL
Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
[TBL] [Abstract][Full Text] [Related]
16. Synergistic T-T cell interaction present in alloreactivity: determination of 'MLR helper' T cell subsets.
Asano Y; Komuro T; Tada T
Int Immunol; 1990; 2(12):1203-11. PubMed ID: 1982500
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 derived from biliary epithelial cells may attenuate alloantigen-specific immune responses.
Narumoto K; Saibara T; Maeda T; Onishi S; Hayashi Y; Miyazaki E; Hiroi M; Enzan H; Kobayashi N
Transpl Int; 2000; 13(1):21-7. PubMed ID: 10743685
[TBL] [Abstract][Full Text] [Related]
18. Requirement of the costimulatory signal in xeno-MHC-restricted helper T-cell activation.
Iwata H; Mori Y; Takagi H; Hirota T; Iida Y; Umeda Y; Matsuno Y; Marui T; Shimabukuro K; Yoshikawa S; Hirose H
Transplant Proc; 2002 Aug; 34(5):1453-5. PubMed ID: 12176436
[No Abstract] [Full Text] [Related]
19. [Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation].
Geissler EK; Scherer MN; Jauch KW; Graeb C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):641-4. PubMed ID: 14518333
[TBL] [Abstract][Full Text] [Related]
20. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
